DJIA 18,288.63 155.93 0.86%
NASDAQ 5,008.10 44.57 0.90%
S&P 500 2,117.39 12.89 0.61%
market minute promo

VIVUS, Inc. (NASDAQ: VVUS)

2.77 0.16 (6.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VVUS $2.77 6.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.63
Previous Close $2.61
Daily Range $2.59 - $2.78
52-Week Range $2.41 - $6.40
Market Cap $287.8M
P/E Ratio -3.26
Dividend (Yield) $0.00 (0.0%)
Volume 3,829,040
Average Daily Volume 1,904,188
Current FY EPS -$1.24

Sector

Healthcare

Industry

Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary Rss Feed

Orexigen Therapeutics, Inc. Gives the Skinny on Its Drug Launch

Fourth-quarter earnings were nothing to get excited about, but the Contrave launch trajectory looks good so far.

Vivus - Flat Qsymia Scripts Point To Needed Shift

Vivus Sinking With Dwindling Qsymia Market Share

Orexigen's Q4 Results Disappoint, But Contrave Is Gaining Market Share

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

VIVUS Q4 Loss Wider than Expected, Qsymia Disappoints - Analyst Blog

Why Vivus Inc Plummeted Today

Vivus Inc shares tanked today following results that failed to impress.

JPM Securities Picks Through Biotech News For Winners

Wednesday's #PreMarket Movers: Hewlett-Packard, Dreamworks Animation Trending Lower

VIVUS' (VVUS) CEO Seth Fischer on Q4 2014 Results -- Earnings Call Transcript

See More VVUS News...

VVUS's Top Competitors

VVUS $2.77 (6.13%)
Current stock: VVUS
JNJ $103.22 (0.69%)
Current stock: JNJ
PFE $34.77 (1.31%)
Current stock: PFE
RHHBY $33.99 (-0.42%)
Current stock: RHHBY